Skip to content

Menu

Home
Our Mission
- ATACH’s National Council
Issues
Newsroom
- Events
Committees
Contact
Become a Member

Close Menu

September 14 2023

Distressed Cannabis M&A Webinar

American Trade Association for Cannabis & Hemp Responds to HHS Recommendation for Cannabis to be Reclassified as a Schedule III Drug under the Controlled Substances Act Duane Morris Alert: Tax Implications of Reclassifying Cannabis as a Schedule III Controlled Substance

Related Posts

Screenshot 2024-02-21 at 11.51.58 PM

Mainstreaming Cannabis: Internal Revenue Code 280E and Tax Efficiency

header

Mainstreaming Cannabis: Bankruptcy, Receiverships and Reorganization

ATACH Cabana At Benzinga

Recent Posts

ATACH Statement on California Governor’s Action on Hemp Regulation
The Rising Tidal Wave of Unregulated Hemp-Derived Synthetic THC Products: Why States Must Regulate Now
ATACH statement on House Agriculture Committee Intoxicating Hemp Vote
American Trade Association for Cannabis and Hemp Responds to Cannabis Rescheduling Rule Moving Forward
ATACH Applauds Groundbreaking Decision By DEA Will Move Cannabis to Schedule III

Archives

Refund/Cancellation Policy
Terms & Conditions
Privacy Policy

© American Trade Association of Cannabis and Hemp 2024